Fusion biopsy is primarily used for prostate cancer diagnosis, although it also has applications in kidney cancer and other areas. The prostate cancer diagnosis segment generated the highest ...

18 Muscle paralysis was first administered, then 10 test pulses were delivered to verify the actual electrical ... with MRI fusion and one (4%) with MRI gantry biopsy of the prostate.

As these elderly individuals grows globally, the incidence of prostate cancer is also expected to increase leading to increased demand for advanced diagnostic technologies such as fusion biopsy.

Fusion biopsy market size was valued at USD 829.1 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2034. The market's rapid expansion is driven by ...

The global fusion biopsy market is valued at an estimated USD 0.65 billion in 2024 and is projected to reach USD 0.91 billion by 2029, at a CAGR of 7.1% during the forecast period. The elderly ...

DELRAY BEACH, Fla., Dec. 13, 2024 /PRNewswire/ -- The global fusion biopsy market is projected to grow at a compound annual growth rate (CAGR) of 7.1%, increasing from an estimated USD 0.65 ...

Fusion Biopsy market is estimated to be valued at USD 791.1 Mn in 2025 and is expected to reach USD 1,418.2 Mn by 2032 exhibiting a CAGR of 8.7% from 2025-2032. Rising prostate cancer cases drive ...